S&P MERVAL Index Ends 1.33% Lower at 1444215.47 — Data Talk
The S&P MERVAL Index is down 19408.31 points or 1.33% today to 1444215.47
--Fourth highest close in history
--Down for two consecutive trading days
--Down 51611.17 points or 3.45% over the last two trading days
--Largest two-day point and percentage decline since Wednesday, April 24, 2024
--Off 3.45% from its record close of 1495826.64 hit Monday, May 6, 2024
--Today's closing value is the fourth highest this year
--Off 3.45% from its 52-week high of 1495826.64 hit Monday, May 6, 2024
--Up 365.13% from its 52-week low of 310497.17 hit Wednesday, May 10, 2023
--Rose 365.13% from 52 weeks ago
--Off 3.45% from its 2024 closing high of 1495826.64 hit Monday, May 6, 2024
--Up 55.22% from its 2024 closing low of 930419.67 hit Tuesday, Jan. 2, 2024
--Month-to-date it is up 9.11%
--Year-to-date it is up 514511.28 points or 55.34%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 08, 2024 17:15 ET (21:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Lowe’s Stock a Buy, Sell, or Fairly Valued?
-
5 Stocks With the Largest Fair Value Estimate Cuts After Q1 Earnings
-
10 Stocks With the Largest Fair Value Estimate Increases After Q1 Earnings
-
Markets Brief: Inflation Back in the Spotlight
-
AI Is Booming, but Consumer Spending Is Slowing. Which Will Prevail in the Stock Market?
-
What’s Happening In the Markets This Week
-
Is the Era of Volatility-Suppressing Policies Possibly Over?
-
5 Undervalued Stocks That Crushed Earnings for Q1 2024
-
Chewy Earnings: Market Likes Repurchase Program and Profit Improvements
-
This 5-Star Stock With a Dividend Yield That Tops 4% Is a Buy
-
After Earnings, Is Target Stock a Buy, Sell, or Fairly Valued?
-
Obesity Drug Stocks: Where to Invest Now
-
How to Invest Like Warren Buffett
-
DuPont Split Gives Investors Better Choices
-
2 Wide-Moat Stocks to Consider
-
Live Nation: Breakup Sought by Department of Justice Probably Wouldn’t Affect Fair Value Much